Thirteen,30 In addition, CCL2 is described to boost osteoclastogenesis by inducing the expression of receptor activator of NF-κB (RANK) by osteoclast progenitors.31 RANK ligand (RANKL) more encourages the differentiation of osteoclast progenitors into useful osteoclasts, which could aggravate DP by producing alveolar bone resorption.32 These results suggest that CCL2 inhibition https://c64621098.blogpostie.com/48916002/a-review-of-st7612aa1